← Eichor
Condition: Juvenile Dermatomyositis Jdm Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Juvenile Dermatomyositis Jdm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History of Inflammatory Muscle Diseases
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT05738824Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06569472Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositi
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT00059748Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Phase N/A · 9 location(s) · Peking Union Medical College Hospital · NCT06417502Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
Phase N/A · 1 location(s) · Central Hospital, Nancy, France · NCT06004817Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07184450Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Phase 1/Phase 2 · 3 location(s) · Cartesian Therapeutics · NCT07089121RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic I
Phase 2/Phase 3 · 35 location(s) · Cabaletta Bio · NCT06154252Environmental Risk Factors for the Anti-synthetase Syndrome
Phase N/A · 8 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT01276470Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refracto
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06686524FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT07111065Adult and Juvenile Myositis
Phase N/A · 4 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT00017914MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Phase N/A · 1 location(s) · Myositis International Health & Research Collaborative Allia · NCT07374107
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.